Inclusion of inflammation markers (e.g. C-reactive protein) and information on non-alcoholic fatty liver disease may have enabled us to categorise more precisely into metabolically healthy vs unhealthy. The gene discussed is CRP; the disease is alcoholic fatty liver disease.